Luther King Capital Management (LKCM)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-41,760
Closed -$2.65M 619
2021
Q3
$2.65M Hold
41,760
0.01% 273
2021
Q2
$3.82M Hold
41,760
0.02% 244
2021
Q1
$2.84M Sell
41,760
-1,245
-3% -$96.7K 0.02% 254
2020
Q4
$3.12M Sell
43,005
-4,420
-9% -$256K 0.02% 231
2020
Q3
$1.8M Hold
47,425
0.01% 272
2020
Q2
$1.68M Buy
+47,425
New +$1.35M 0.01% 255

Other funds holding CDNA

Luther King Capital Management (LKCM)'s CDNA Position: Q4 2021 in Review

Luther King Capital Management (LKCM) sold out of CareDx (CDNA) in Q4 2021, closing a stake of 41,760 shares — an estimated $2.65M sold.

Luther King Capital Management (LKCM) first reported a position in CDNA in Q2 2020 and held it in 6 quarters. The position peaked at $3.82M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Luther King Capital Management (LKCM) reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 41,760 CareDx shares in Q4 2021, an estimated $2.65M.
  • Luther King Capital Management (LKCM) first reported a position in CareDx in Q2 2020 and held it in 6 quarters.
  • Luther King Capital Management (LKCM)'s CareDx position peaked at $3.82M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q4 2021, filed 14 Feb 2022.